IDEXX Laboratories Inc. shares fall 1.16 percent to $568.30
Updated
Updated · MarketWatch · Apr 28
IDEXX Laboratories Inc. shares fall 1.16 percent to $568.30
15 articles · Updated · MarketWatch · Apr 28
The decline on Tuesday ended a two-day winning streak for IDEXX Laboratories Inc., with trading volume reaching 529,698, above its 50-day average.
IDEXX underperformed the broader market, as the S&P 500 dropped 0.49% and the Dow Jones fell 0.05%.
The stock now stands 26.19% below its 52-week high of $769.98, set on November 26, and showed mixed performance compared to competitors Johnson & Johnson, Medtronic, and Boston Scientific.
Is IDEXX's 26% stock dip a buying opportunity, or do market fears signal more trouble ahead?
Why are insiders selling millions in IDEXX stock despite the company's record financial outlook?
Can a new CEO help IDEXX outpace its rivals in the rapidly growing veterinary technology market?
Will IDEXX's AI-driven diagnostics create a new divide in the quality of animal healthcare?
How will the UAE's OPEC exit and rising oil prices affect the resilient pet care industry?
With fewer vet visits but higher spending, what does this trend reveal about the future of pet ownership?